Notizia

The latest pharma, healthcare and biotech news on drug approvals, clinical trial failures, big pharma mergers and licensing of drugs.

GBT, Syros; Takeda, Cevance collaborates; IND application to ZN-c3

Articles, Business Consultant, DelveInsight's Indication Pipeline Reports, Notizia, Pharma Consultant, The Business Cocktail

Global Therapeutics and Syros Pharmaceuticals have teamed up to move forward to discover, develop and market novel Sickle cell disease and...

Read More

Omega’s sixth funding round; Correvio’s drug failure; and BIMA acquisition

Business Consultant, DelveInsight's Oncology based Reports, Notizia, Pharma Consultant, The Business Cocktail

A leading global international investment firm, Omega Funds has announced the closure of its sixth fundraising USD 438 Million. More than...

Read More

Toujeo to treat Type 1 Diabetes; TauRx for Alzheimer’s patients

Business Consultant, DelveInsight's Drug Report, Notizia, Pharma Consultant, The Business Cocktail

Sanofi’s Toujeo has received FDA recommendation for its expanded use in Type 1 Diabetes. Toujeo is an insulin glargine injection to...

Read More

GHO to advance healthcare in Europe; Truvian nets USD 27.1 Mn; Lilly plans its diabetes portfolio expansion

Business Consultant, DelveInsight's Indication Pipeline Reports, Notizia, Pharma Consultant, The Business Cocktail

Global Healthcare Opportunities (GHO) Capital, a London-based healthcare investment firm, has recently netted USD 1.1 Billion to advance...

Read More

Nordisk ties up with Dicerna; Pfizer’s drug gets FDA nod

Business Consultant, DelveInsight's Drug Report, Notizia, Pharma Consultant, The Business Cocktail

Novo Nordisk has announced to enter into a collaboration with Dicerna’s RNAi platform to focus on metabolic and liver-related diseases....

Read More
Close